The tyrosine kinase inhibitor nilotinib targets the discoidin domain receptor DDR2 in calcific aortic valve stenosis.

Autor: Carracedo, Miguel1 (AUTHOR), Pawelzik, Sven‐Christian1,2 (AUTHOR), Artiach, Gonzalo1 (AUTHOR), Pouwer, Marianne G.3 (AUTHOR), Plunde, Oscar1,2 (AUTHOR), Saliba‐Gustafsson, Peter1 (AUTHOR), Ehrenborg, Ewa1 (AUTHOR), Eriksson, Per1 (AUTHOR), Pieterman, Elsbet3 (AUTHOR), Stenke, Leif1,4 (AUTHOR), Princen, Hans M. G.3 (AUTHOR), Franco‐Cereceda, Anders2,5 (AUTHOR), Bäck, Magnus1,2 (AUTHOR) magnus.back@ki.se, Pawelzik, Sven-Christian1,2 (AUTHOR), Saliba-Gustafsson, Peter1 (AUTHOR), Franco-Cereceda, Anders2,5 (AUTHOR)
Zdroj: British Journal of Pharmacology. Oct2022, Vol. 179 Issue 19, p4709-4721. 13p. 1 Color Photograph, 3 Charts, 3 Graphs.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje